VivaZome to collaborate with ANU retinal disease experts to develop exosome-based therapies
Posted: 27 January 2022 VivaZome Therapeutics Pty Ltd has announced its participation in a collaborative project with researchers at the Australian National University (ANU) and other expert groups focussing on improved therapies for age-related macular degeneration (AMD). The…
PRAXIS Australia training solutions
Posted 27 January 2022 Your learning needs are unique. Create a learning program tailored specifically to you with PRAXIS Australia’s Core Skill Sets program. A customised program ensures you develop the appropriate skills you need for your specific…
4DMedical teaming with Alfred Health to apply four-dimensional imaging in lung transplant patient assessment
Posted: 25 January 2022 Lung transplants offer people afflicted with incurable respiratory disease the prospect of a better quality of life − however such procedures are expensive, resource-intensive and with no guarantee of long-term success. The ‘FIT’ (or…
COVALIA study update: Safety Results from needle-free SARS-CoV2 DNA vaccine phase 1 trial
Posted: 21 January 2022 First needle-free SARS-CoV2 DNA vaccine tested in Australia is well tolerated No safety concerns were observed Ongoing study enrolment for booster dose Technovalia, an Australian biotech vaccine developer has announced the interim safety results…
Sophie Stocker receives grant to lead charge for precision medicine research
Posted: 20 December 2021 Dr. Sophie Stocker, a senior lecturer at the University of Sydney, has been awarded a Ramaciotti Health Investment Grant of close to $100,000 by the Clive and Vera Ramaciotti Foundations to undertake medical research for precision medicine using a…
MedTech Innovator Asia Pacific 2022 Accelerator Program – Applications now open
Posted: 13 December 2021 About MedTech Innovator Asia Pacific MedTech Innovator is the medical technology industry’s global showcase and accelerator for innovative medical device, digital health and diagnostic companies. The mission is to improve the lives of patients…
2022 ANDHealth+ cohort announced
Posted: 13 December 2021 BioMelbourne Network Member, ANDHealth, have welcomed the five companies selected for the 2022 ANDHealth+ program, Australia’s leading commercialisation program for digital health. The successful companies were announced by Dr Katie Allen, MP, Member for…
Inhaled AD-214 passes first development milestone
Posted: 13 December 2021 BioMelbourne Network Member, AdAlta Limited, the clinical stage drug discovery company developing novel therapeutic products from its i-body platform, is pleased to announce that initial testing of AD-214 in nebulisation devices has exceeded expectations.…
BioMelbourne Network acknowledges The Honourable Greg Hunt MP
Posted 8 December BioMelbourne Network acknowledges and expresses its gratitude to the Minister for Health and Aged Care, The Honourable Greg Hunt MP, who has announced his retirement from politics prior to the next Federal election. Greg was…
$5M Boost to Innovation in Australia with New Illumina Genomics Lab
Posted 2 December New laboratory opens in Melbourne Biomedical Precinct to accelerate the adoption of genomics in healthcare and agriculture in Australia. Illumina, Inc. (NASDAQ: ILMN), the global leader in genomics, today announced the opening of a new,…
Universal Biosensors Update
Posted: 1 December 2021 Below is an update from BioMelbourne Network Member Universal Biosensors. Sentia Universal Biosensors’ (UBI) development of our new Glucose, Fructose and Malic Acid biosensors for the wine industry is approaching completion with product release…
2021 BioMelbourne Network Annual General Meeting wrap
Posted: 1 December 2021 The 2021 BioMelbourne Network Annual General Meeting and Networking Event was held on Tuesday 30 November virtually via Zoom. Honorary Life Membership awards BioMelbourne Network bestows Honorary Life Membership awards on Members whose service…
